10X Genomics Dividends
| TXG Stock | USD 15.90 0.42 2.71% |
The current Dividend Paid And Capex Coverage Ratio is estimated to decrease to -0.32. 10X Genomics' past performance could be the main factor of why investors trade 10X Genomics stock today. Investors should clearly understand every aspect of the 10X Genomics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest 10X Genomics' dividend schedule and payout information. 10X Genomics dividends can also provide a clue to the current valuation of 10X Genomics.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | (0.31) | (0.32) |
10X |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in 10X Genomics must own a stock before its ex-dividend date to receive its next dividend.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 10X Genomics. If investors know 10X will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 10X Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.52) | Revenue Per Share 5.261 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) | Return On Equity (0.25) |
The market value of 10X Genomics is measured differently than its book value, which is the value of 10X that is recorded on the company's balance sheet. Investors also form their own opinion of 10X Genomics' value that differs from its market value or its book value, called intrinsic value, which is 10X Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 10X Genomics' market value can be influenced by many factors that don't directly affect 10X Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 10X Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if 10X Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 10X Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.